Faculty, Staff and Student Publications
Open-access journal articles from UTHealth GSBS faculty, staff and students.
Submissions from 2022
Pramlintide: A Novel Therapeutic Approach for Osteosarcoma through Metabolic Reprogramming, Yuanzheng Yang, Zhanglong Peng, Elsa R Flores, et al.
Targeting Syndecan-1: New Opportunities in Cancer Therapy, Zecheng Yang, Shuaitong Chen, Haoqiang Ying, et al.
Evaluation of Allogeneic and Autologous Membrane-Bound Il-21-Expanded Nk Cells for Chronic Lymphocytic Leukemia Therapy, Max Yano, Chia Sharpe, J Rachel Lance, et al.
Prodrugs of a 1-Hydroxy-2-Oxopiperidin-3-Yl Phosphonate Enolase Inhibitor for the Treatment of ENO1-Deleted Cancers, Victoria C Yan, Cong-Dat Pham, Elliot S Ballato, et al.
LIF-Ting Ferroptosis To Improve Liver Cancer Therapy, Fan Yao, Yang Zhao, and Li Ma
DLL3 as an Emerging Target for the Treatment of Neuroendocrine Neoplasms, James Yao, Emily Bergsland, Rahul Aggarwal, et al.
Residual Cancer Burden After Neoadjuvant Chemotherapy and Long-Term Survival Outcomes in Breast Cancer: A Multicentre Pooled Analysis of 5161 Patients, Christina Yau, Marie Osdoit, Marieke van der Noordaa, et al.
Cerebrovascular Reactivity Mapping Using Resting-State Functional MRI in Patients With Gliomas, Mei-Yu Yeh, Henry S Chen, Ping Hou, et al.
Intensity-Modulated Radiation Therapy Reduces Patient-Reported Chronic Toxicity Compared With Conventional Pelvic Radiation Therapy: Updated Results of a Phase III Trial, Anamaria R Yeung, Snehal Deshmukh, Ann H Klopp, et al.
Advances in Head and Neck Cancer Pain, Y Ye, D D Jensen, C T Viet, et al.
Hypomethylating Agent and Venetoclax With FLT3 Inhibitor “Triplet” Therapy in Older/Unfit Patients With FLT3 Mutated AML, Musa Yilmaz, Hagop Kantarjian, Nicholas J Short, et al.
Lenvatinib Plus Pembrolizumab in Japanese Patients With Endometrial Cancer: Results From Study 309/Keynote-775, Kan Yonemori, Mayu Yunokawa, Kimio Ushijima, et al.
Association of PD-L1 Expression and Other Variables With Benefit From Immune Checkpoint Inhibition in Advanced Gastroesophageal Cancer: Systematic Review and Meta-analysis of 17 Phase 3 Randomized Clinical Trials, Harry H Yoon, Zhaohui Jin, Oudom Kour, et al.
lncRNAs UC145 and PRKG1-AS1 Determine the Functional Output of DKK1 in Regulating the Wnt Signaling Pathway in Gastric Cancer, Jung-Ho Yoon, Hyojoo Byun, Cristina Ivan, et al.
Expression of P-STAT3 and C-Myc Correlates With P2-HNF4α Expression in Nonalcoholic Fatty Liver Disease (NAFLD), Mamoun Younes, Lin Zhang, Baharan Fekry, et al.
Targeting IL-1β as an Immunopreventive and Therapeutic Modality for K-Ras-Mutant Lung Cancer, Bo Yuan, Michael J Clowers, Walter V Velasco, et al.
Vitamin E Enhances Cancer Immunotherapy by Reinvigorating Dendritic Cells via Targeting Checkpoint SHP1, Xiangliang Yuan, Yimin Duan, Yi Xiao, et al.
Alternative Adenosine Receptor Activation: The Netrin-Adora2B Link, Xiaoyi Yuan, Tingting Mills, Marie-Francoise Doursout, et al.
Multi-Organ Segmentation of Abdominal Structures From Non-Contrast and Contrast Enhanced CT Images, Cenji Yu, Chidinma P Anakwenze, Yao Zhao, et al.
Enzymatic Characterization of mRNA Cap Adenosine-N6 Methyltransferase PCIF1 Activity on Uncapped RNAs, Dan Yu, Nan Dai, Eric J Wolf, et al.
Enzymatic Characterization of In Vitro Activity of RNA Methyltransferase PCIF1 on DNA, Dan Yu, Jujun Zhou, Qin Chen, et al.
Targetable Vulnerability of Deregulated FOXM1/PLK1 Signaling Axis in Diffuse Large B Cell Lymphoma, Fang Yu, Hua He, Loretta J Nastoupil, et al.
Immune Checkpoint Inhibitor-Related Gastrointestinal Toxicity in Patients With Malignancy Involving the Luminal Gastrointestinal Tract and Its Impact on Cancer Outcomes, Kevin Yu, Antony Mathew, Fiyinfoluwa Abraham, et al.
Omics Analyses of a Somatic Trp53R245W/+ Breast Cancer Model Identify Cooperating Driver Events Activating PI3K/AKT/mTOR Signaling, Xiaojie Yu, Yun Zhang, Shunbin Xiong, et al.
A Whole-Exome Case-Control Association Study To Characterize the Contribution of Rare Coding Variation to Pancreatic Cancer Risk, Yao Yu, Kyle Chang, Jiun-Sheng Chen, et al.